Control Strategy Development for Continuous Drug Substance and Drug Product Manufacture

Chair(s):
Marek, J. C., AbbVie, Inc.
Co-chair(s):
Yazdanpanah, N., Food and Drug Administration

These sessions highlight the methodologies and examples of selection and monitoring of critical quality attributes (CQA) to ensure robust manufacturing process and desired performance in drug substance or drug product processes. Examples of the challenges and successes associated with the development and implementation of advanced control strategies, such as model predictive control and multivariate control, are discussed in these sessions. Examples of academic and industrial research involving the novel use of Process Analytical Technology (PAT) Tools for on-line monitoring of CQAs, applications of lab-based PAT to either identify scalable process fingerprints or determine clinically relevant process endpoints, and advancements in technologies and methods toward real-time monitoring and release are also of interest in these sessions. Submissions to sessions I-III of this topic are considered for oral presentations.

Papers:

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing


Individuals

2018 AIChE Annual Meeting
AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00
Pharmaceutical Discovery, Development and Manufacturing Forum only
AIChE Members $100.00
AIChE Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $150.00